Nọmba Cas: 168273-06-1 Ụdị Molecular: C22H21Cl3N4O
Ebe Na-agbaze | 154.7 Celsius C |
Njupụta | 1.299 |
nchekwa okpomọkụ | enweghị mgbochi. |
solubility | Soluble na DMSO (ruo 20 mg / ml) ma ọ bụ na ethanol (ruo 20 mg / ml).dimethyl sulfoxide na insoluble na benzene ma ọ bụ hexane. |
ngwa anya ọrụ | N/A |
Ọdịdị | ọcha ka ìhè odo crystal ntụ ntụ |
Ịdị ọcha | ≥98% |
bụ onye na-emegide ndị na-anabata cannabinoid (CB1).Ọ na-eme site na nhọrọ nke igbochi CB1 ndị na-anabata ya dị na ụbụrụ yana akụkụ ahụ dị mkpa na glucose na metabolism lipid, gụnyere anụ ahụ adipose, imeju, tract gastrointestinal, na muscle.Ya mere, bụ usoro ọgwụgwọ maka oke ibu na ihe ize ndụ nke obi.Dị ka ọgwụ mgbochi oke ibu nke anorectic, a na-eji ya dị ka ihe mgbakwunye nri na mmega ahụ maka ndị ọrịa buru ibu ma ọ bụ ndị buru ibu nwere ihe ize ndụ metụtara na Europe na 2006. Ka o sina dị, a kọrọ mmetụta ọjọọ gụnyere igbu onwe, ịda mbà n'obi, na nchekasị, dabere na nke a napụrụ rimonadant. gburugburu ụwa na 2008.
Andogenous cannabinoids metụtara mmetụta na-atọ ụtọ nke nicotine, dị ka onye na-anabata ihe na-anabata cannabinoid, ka a na-anwalekwa dị ka ọgwụgwọ nwere ike igbochi ị smokingụ sịga.
bụ immunomodulatory CB1 receptor inverse agonist
Buru ụzọ jụọ ndụmọdụ dọkịta